FDA 510(k) FDA class 2 Unknown 🇺🇸 United States

LZI Carisoprodol Metabolite (Meprobamate) Enzyme Immunoassay

K Number: DEN170010 · Decision Apr 20, 2018
Classifications
1
FEI Numbers
4
Registration Numbers
4
Same Product Code
1
Applicant Total
50
Review Days
423

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
LZI Carisoprodol Metabolite (Meprobamate) Enzyme Immunoassay
K Number
DEN170010
Device Class
FDA class 2
Clearance Type
Direct
Regulation Number
862.3590
Medical Specialty
Clinical Toxicology
Decision
Unknown
Applicant
Lin-Zhi International, Inc.
Date Received
February 21, 2017
Decision Date
April 20, 2018
Product Code
QBK
Advisory Committee
Clinical Toxicology
Review Advisory Committee
TX
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
QBK Meprobamate Test System

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (QBK), ordered by most recent decision date.

View all

Other Clearances by Lin-Zhi International, Inc.

K Number Device Name
K253082 LZI Buprenorphine II Enzyme Immunoassay
K251634 LZI Fentanyl III Enzyme Immunoassay
K202007 LZI Oxycodone III Enzyme Immunoassay
K201938 LZI Fentanyl II Enzyme Immunoassay
K201223 LZI Tramadol Enzyme Immunoassay
K192299 LZI Cotinine II Enzyme Immunoassay
K192433 LZI Methadone II Enzyme Immunoassay
K181159 LZI Fentanyl Enzyme Immunoassay
K170416 LZI Methadone Metabolite Enzyme Immunoassay, LZI Methadone Metabolite (100 and 300) Calibrators
K141320 LZI Oral Fluid Cannabinoids Enzyme Immunoassay, LZI Oral Fluid Cannabinoids Calibrators and LZI Oral Fluid Cannabinoids Controls
Search all 50 clearances from Lin-Zhi International, Inc. →